Library
Usefulness of Plasma Amyloid as a Prescreener for the Earliest Alzheimer Pathological Changes Depends on the Study Population
19 November 2019. doid: 10.1002/ana.25634
Prins S, Zhuparris A, Groeneveld GJ
View publicationAdvancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
